Revista Española de Cardiología | Blog

LATE-BREAKING CLINICAL TRIALS – AHA 2011

| Cardiología Hoy - REC - Blog

El día 12 de Noviembre comienza en Orlando el congreso de la AHA 2011. Tal y como hemos hecho en otras ocasiones, comentaremos en el blog los resultados de los Late-Breaking Clinical Trials.

 

AHA 2011

Domingo, 13 Noviembre 2011

Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention: AIDA STEMI Trial 

Abciximab Plus Unfractionated Heparin versus Bivalirudin in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. The ISAR-REACT 4 Randomized Trial 

Extended Anticoagulant Prophylaxis in Initially Hospitalized Medically Ill Patients: Results of the ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) Trial 

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) Trial

Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51 (ATLAS ACS 2-TIMI 51) Trial: A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects with Acute Coronary Syndrome

Lunes, 14 Noviembre 2011

The Impact of Full Coverage for Preventive Medications After Myocardial Infarction on Recurrent Vascular Events: The Post-MI Free Rx Event and Economic Evaluation (Post-MI FREEE) Trial 

Pharmacist Intervention to Prevent Hospitalization and Death in Patients with Heart Failure: A Prospective Cluster Randomised Controlled Trial 

Testing an Evidence-Based, Individualized Informed Consent Form to Improve Patients’ Experiences with PCI 

Outcomes of Non-Primary PCI at Hospitals with and Without On-Site Cardiac Surgery: A Randomized Study 

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone 50, 100 Or 300 Mg OD with Amiodarone as Calibrator for the Prevention of ICD Interventions or Death (ALPHEE) 

Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: a Multi-center Randomized Clinical Trial 

A Randomized Multicenter Comparison of Radiofrequency Ablation and Antiarrhythmic Drug Therapy as First-Line Treatment in 294 Patients with Paroxysmal Atrial Fibrillation 

The Results of the PALLAS Study 

Martes, 15 Noviembre 2011

Practice-Based Opportunities for Weight Reduction (POWER) 

Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects: SATURN Study Results 

Lipid-Modulating Effects of Evacetrapib, a Novel CETP Inhibitor, Administered as Monotherapy or in Combination with the Most Commonly-Used Statins 

Extended-Release Niacin Does Not Reduce Clinical Events in Patients with Established Cardiovascular Disease Whose LDL-Cholesterol is Optimally Controlled with Statin Therapy: Results from the AIM-HIGH Trial

Miércoles, 16 Noviembre 2011

Randomized Trial of Early Surgery versus Conventional Treatment for Infective Endocarditis (EASE)

Claudication Treatment Comparative Effectiveness: 6 Month Outcomes From the CLEVER Study

Colchicine Reduces Post-Operative Atrial Fibrillation. Results of the COPPS Atrial Fibrillation Study

ELEVATE-TIMI 56: Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56

Advertencia

CARDIOLOGÍA HOY es el blog de la Sociedad Española de Cardiología (SEC), un foro abierto sobre actualidad médico-científica. Los contenidos publicados en este blog están redactados y dirigidos exclusivamente a profesionales de la salud. Las opiniones vertidas en este blog corresponden a los autores de los artículos y no necesariamente reflejan la opinión de la SEC. El Comité TIC de la SEC no aceptará artículos y comentarios al margen de este contexto formativo y de actualización de las evidencias clínicas. Más información sobre las Normas de comportamiento del blog.

¿Te ha gustado el artículo?

Compártelo en las redes sociales:
Colabora enviando tu artículo: Contacta con nosotros